Research: Evaluating Microreactor-Based Process Intensification for Enhanced Pharmaceut...

Research question: How does the implementation of microreactors affect reaction efficiency, selectivity, and scalability in the synthesis of target pharmaceutical compounds compared to conventional batch reactors?

Background & Motivation: The pharmaceutical industry faces increasing demand for efficient, scalable, and sustainable synthesis routes due to regulatory pressure and the need for rapid drug development. Conventional batch reactors often suffer from limitations in heat and mass transfer, leading to lower yields and longer reaction times.

Research Gap / Question: Despite advancements in microreactor technology, comprehensive research comparing their performance to traditional reactors in real pharmaceutical synthesis scenarios remains limited. This project addresses the gap by rigorously evaluating process intensification outcomes using microreactor systems.

Approach & Expected Contribution: The study will select a model pharmaceutical reaction (e.g., the synthesis of a key active pharmaceutical ingredient) and conduct parallel experiments using both microreactor and batch reactor setups. Quantitative analysis of conversion rates, selectivity, product quality, and scalability will be performed. The work aims to generate actionable data and frameworks for evaluating microreactor adoption in pharmaceutical manufacturing.

Why It Matters: Demonstrating the advantages or limitations of microreactors can directly inform process design decisions in pharma, potentially leading to greener, safer, and more cost-effective drug manufacturing processes.